Joseph Kassab MD, MS , Joseph Hajj MD , Serge C. Harb MD , Rhonda Miyasaka MD , Grant Reed MD, MSc , Amar Krishnaswamy MD , Kari Feldt MD , Christopher U. Meduri MD, MPH , A. Marc Gillinov MD , Shinya Unai MD , James J. Yun MD, PhD , Marcus Carlsson MD , Samir R. Kapadia MD , Rishi Puri MD, PhD
{"title":"Mitral Annular Function in Mitral Annular Calcification and Severe Mitral Regurgitation","authors":"Joseph Kassab MD, MS , Joseph Hajj MD , Serge C. Harb MD , Rhonda Miyasaka MD , Grant Reed MD, MSc , Amar Krishnaswamy MD , Kari Feldt MD , Christopher U. Meduri MD, MPH , A. Marc Gillinov MD , Shinya Unai MD , James J. Yun MD, PhD , Marcus Carlsson MD , Samir R. Kapadia MD , Rishi Puri MD, PhD","doi":"10.1016/j.jacadv.2025.102161","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Longitudinal left ventricular (LV) shortening, or mitral atrioventricular plane displacement (AVPD), reflects mitral annular function.</div></div><div><h3>Objectives</h3><div>The authors sought to demonstrate the use of cardiac computed tomography (CCT) to measure mitral AVPD and assess its contribution to LV stroke volume (LVSV) in patients with mitral annular calcification (MAC), severe functional mitral regurgitation (FMR), and severe primary mitral regurgitation (PMR) without MAC.</div></div><div><h3>Methods</h3><div>We included 200 patients with circumferential MAC (age 79.6 ± 10 years), 50 with severe FMR (age 74 ± 8 years), 50 with severe PMR (age 83 ± 10 years), and 50 control subjects (age 41.6 ± 16 years) who underwent CCT (2016-2022). AVPD was measured in all patients. The volume of blood attributable to AVPD (V<sup>AVPD</sup>) and its fractional contribution to LVSV (SV<sup>AVPD%</sup>) were calculated across all cohorts. Group comparisons were performed using <em>t</em>-tests, analysis of variance, and Chi-square tests; multivariable linear regression was used to identify independent associations with AVPD and SV<sup>AVPD%</sup>.</div></div><div><h3>Results</h3><div>Mean AVPD differed significantly between controls, PMR, and FMR patients (11.9, 6.6, 9.9 mm; <em>P</em> < 0.0001), whereas SV<sup>AVPD%</sup> was similar (45.8%, 46.5%, 45.5%; <em>P</em> = 0.94). Among MAC patients, AVPD decreased with increasing severity (<em>P</em> < 0.0001). Those with grade 3 to 4 MAC had significantly lower SV<sup>AVPD%</sup> compared to non-MAC groups (26.7% to 28.9% vs 45.5% to 46.5%; <em>P</em> < 0.0001). MAC severity was independently associated with reduced AVPD and SV<sup>AVPD%</sup> (<em>P</em> < 0.0001).</div></div><div><h3>Conclusions</h3><div>CCT can quantify mitral annular function and its contribution to LVSV. Moderate-to-severe MAC significantly impairs annular function, reducing its share of LVSV. These findings may inform patient selection for transcatheter mitral therapies that impact annular dynamics.</div></div>","PeriodicalId":73527,"journal":{"name":"JACC advances","volume":"4 10","pages":"Article 102161"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC advances","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772963X25005861","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Longitudinal left ventricular (LV) shortening, or mitral atrioventricular plane displacement (AVPD), reflects mitral annular function.
Objectives
The authors sought to demonstrate the use of cardiac computed tomography (CCT) to measure mitral AVPD and assess its contribution to LV stroke volume (LVSV) in patients with mitral annular calcification (MAC), severe functional mitral regurgitation (FMR), and severe primary mitral regurgitation (PMR) without MAC.
Methods
We included 200 patients with circumferential MAC (age 79.6 ± 10 years), 50 with severe FMR (age 74 ± 8 years), 50 with severe PMR (age 83 ± 10 years), and 50 control subjects (age 41.6 ± 16 years) who underwent CCT (2016-2022). AVPD was measured in all patients. The volume of blood attributable to AVPD (VAVPD) and its fractional contribution to LVSV (SVAVPD%) were calculated across all cohorts. Group comparisons were performed using t-tests, analysis of variance, and Chi-square tests; multivariable linear regression was used to identify independent associations with AVPD and SVAVPD%.
Results
Mean AVPD differed significantly between controls, PMR, and FMR patients (11.9, 6.6, 9.9 mm; P < 0.0001), whereas SVAVPD% was similar (45.8%, 46.5%, 45.5%; P = 0.94). Among MAC patients, AVPD decreased with increasing severity (P < 0.0001). Those with grade 3 to 4 MAC had significantly lower SVAVPD% compared to non-MAC groups (26.7% to 28.9% vs 45.5% to 46.5%; P < 0.0001). MAC severity was independently associated with reduced AVPD and SVAVPD% (P < 0.0001).
Conclusions
CCT can quantify mitral annular function and its contribution to LVSV. Moderate-to-severe MAC significantly impairs annular function, reducing its share of LVSV. These findings may inform patient selection for transcatheter mitral therapies that impact annular dynamics.